Amarin Corp. plc
(NASDAQ: AMRN)
|
12:26 PM EDT, 05/24/22 | |||
---|---|---|---|---|
Last: $1.32 | Change: -0.09 | %Change: -6.38% | Volume: 1,106,317 |
Open: | $ 1.40 | Volume: | 1,106,317 | |
---|---|---|---|---|
High: | $ 1.41 | Yield(%) | 0.00 | |
Low: | $ 1.31 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 559.69M | |
EPS ($) | -0.06 | Shares Out: | 396.94M |
% Price Change (last 4 weeks): | -53.31 |
---|---|
% Price Change (last 13 weeks): | -57.40 |
% Price Change (last 26 weeks): | -62.70 |
% Price Change (last 52 weeks): | -68.03 |
% Price Change (year to date): | -59.83 |
Return on Equity (%): | 1.19 |
---|---|
Return on Assets (%): | 0.76 |
Return on Invested Capital (%): | -45.98 |
Gross Profit Margin (%): | 78.71 |
---|---|
Net Profit Margin (%): | 1.33 |
Operating Profit Margin (%): | 4.15 |
|
|
50-day Moving Average: | $2.68 |
---|---|
200-day Moving Average: | $3.81 |
Avg. Daily Vol. (last 50 days): | 4,185,785 |
Avg. Daily Vol. (last 200 days): | 3,839,278 |
52-wk high: | $5.97 |
52-wk low: | $1.11 |
Bid: | $1.32 |
Ask: | $1.33 |
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
|
Amarin Corp. plc
77 Sir John Rogerson's Quay Spaces Southl Docklands Block C Dublin DU 2 Phone: 353.1.6699020 Fax: 353.1.6699028 http://www.amarincorp.com |
Earnings (1year) ($): | -0.06 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 1.68 |
Cash Flow ($): | 0.03 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 2.33 |
Price/Book (x): | 2.00 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.74 |
---|---|
Current Ratio (x): | 2.37 |
LT Debt/Equity (x): | 1.29 |
Total Debt/Equity (x): | 1.55 |